Meijer Cold and Hot Pain Relieving

Description

The drug is identified by SPL Code 34089-3 and is presented as a white to off-white powder. Its chemical name is insert chemical name here. The formulation includes inactive ingredients, which are insert inactive ingredients here.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with arthritis, simple backache, muscle strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to instruct patients to shake the product well before use. For adults and children aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. For children under 12 years of age, it is essential to consult a physician prior to use.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Warnings and Precautions

This product is intended for external use only and is flammable; therefore, it must be kept away from fire or flame. Healthcare professionals should advise patients to avoid contact with the eyes during application. In the event of eye contact, it is imperative to flush the eyes thoroughly with water. The product should not be applied to wounds or damaged skin, and it is essential to avoid tight bandaging of the area treated. Additionally, the use of heating pads in conjunction with this product is contraindicated.

The contents of this product are under pressure; thus, it should not be punctured or incinerated. Storage must be at temperatures not exceeding 120°F to maintain product integrity.

Patients should be instructed to discontinue use and consult a healthcare provider if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. In cases of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of several important safety warnings and potential adverse reactions. This product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. Users must avoid contact with the eyes; in the event of contact, it is crucial to flush the eyes thoroughly with water.

The product should not be applied to wounds or damaged skin, and it is advised not to bandage the area tightly after application. Additionally, the use of this product in conjunction with a heating pad is contraindicated. The contents are under pressure, and users should not puncture or incinerate the container. It is also important to store the product at temperatures not exceeding 120°F.

Patients are advised to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Drug Interactions

No drug interactions have been identified in the available data. Additionally, there are no reported interactions between drugs and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Meijer Cold and Hot Pain Relieving (menthol 16%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. For adolescents and children aged 12 years and older, the recommended application is to the affected area not more than 3 to 4 times daily.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of Meijer Cold and Hot Pain Relieving menthol 16% spray during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when recommending this product to women of childbearing potential and consider the absence of data when assessing the potential risks and benefits for pregnant patients.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers on the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as indicated based on the clinical scenario and the substance involved. Continuous assessment and supportive care are critical in managing the patient's condition effectively.

Healthcare professionals are encouraged to report any cases of overdose to the appropriate regulatory authorities and to consult poison control centers for additional guidance on management strategies.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that in the event of accidental ingestion, it is crucial to seek medical assistance immediately or contact a Poison Control Center. This prompt action is essential to ensure the safety and well-being of the patient.

Storage and Handling

The product is supplied in a container that is under pressure. It is essential to avoid storing the product at temperatures exceeding 120°F. Care should be taken to prevent puncturing or incinerating the container, as this may lead to hazardous situations. Proper handling and storage conditions are crucial to ensure the safety and efficacy of the product.

Additional Clinical Information

Patients aged 12 years and older are advised to apply the product to the affected area no more than 3 to 4 times daily. For children under 12 years of age, consultation with a doctor is recommended prior to use.

Clinicians should counsel patients on the following safety precautions: the product is for external use only and is flammable, necessitating avoidance of fire or flame. Patients should avoid contact with eyes; in case of contact, they should flush thoroughly with water. The product should not be applied to wounds or damaged skin, nor should it be bandaged tightly or used with a heating pad. It is important to note that the contents are under pressure, and patients should not puncture or incinerate the container. Storage should not exceed 120°F. Patients should discontinue use and consult a doctor if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and recur within a few days. In the event of ingestion, immediate medical assistance or contact with a Poison Control Center is necessary. Patients are also advised to shake the product well before use.

Drug Information (PDF)

This file contains official product information for Meijer Cold and Hot Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)